Melkersson–Rosenthal syndrome: a case report of a rare disease with overlapping features
Open Access
- 5 January 2019
- journal article
- research article
- Published by Springer Science and Business Media LLC in Allergy, Asthma & Clinical Immunology
- Vol. 15 (1), 1
- https://doi.org/10.1186/s13223-018-0316-z
Abstract
Melkersson–Rosenthal syndrome (MRS) is a rare, neuro-mucocutaneous disease which presents as orofacial swelling, facial palsy and fissured tongue. These symptoms may occur simultaneously or, more frequently, with a oligosymptomatic or monosymptomatic pattern. Swelling, that is the most common initial finding, may mimic hereditary or acquired angioedema, a disorder caused by histamine or bradykinin-mediated plasma-leakage affecting subcutaneous and/or submucosal tissue. The differential diagnosis of MRS includes also chronic inflammatory and infective diseases characterized by granulomatous infiltration, as well as rosacea, contact dermatitis, allergic reactions and Bell’s palsy. A 71-year old, non-allergic female patient with no familial and personal history of angioedema presented, a few days after a possible herpes simplex or varicella-zoster virus infection, with monolateral facial paraesthesia and lower lip edema. After temporary remission of symptoms on oral steroids and antihistamines, she showed swelling recurrence refractory to valaciclovir therapy and a subsequent course of antihistamines. The clinical picture and a previous history of non-Hodgkin lymphoma prompted us to rule out an acquired form of paraneoplastic, C1-inhibitor (C1-INH) deficiency: C1q and both antigen and functional C1-INH tested normal, whilst we found low plasma levels of C3 and C4 possibly related to the parallel detection of antiphospholipid antibodies. Thus, we hypothesized a non-histaminergic, idiopathic form of angioedema and planned further therapy with tranexamic acid and the leukotriene receptor antagonist montelukast. Treatment failure with both drugs finally suggested a Melkersson–Rosenthal syndrome, which was confirmed by histologic findings of non caseating granulomas on lip biopsy. Melkersson–Rosenthal syndrome may occur with rather non-specific symptoms and overlap with alternative conditions, including recurrent angioedema. No specific biomarkers for MRS exist and clinical diagnosis is often of exclusion. The finding of complement or immune alterations, as in our patient, may be further confounding and justify the need for skin or mucosal biopsy to establish a correct diagnosis and prescribe targeted therapy.Keywords
This publication has 17 references indexed in Scilit:
- Melkersson-Rosenthal syndrome: a retrospective study of 44 patientsActa Oto-Laryngologica, 2014
- Tranexamic acid as maintenance treatment for non-histaminergic angioedema: analysis of efficacy and safety in 37 patientsClinical and Experimental Immunology, 2014
- Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working GroupAllergy, 2014
- Cheilitis Granulomatosa: A ReviewHead and Neck Pathology, 2013
- Guidance for diagnosis and treatment of acute angioedema in the emergency department: consensus statement by a panel of Italian expertsInternal and Emergency Medicine, 2013
- Complement Diagnostics: Concepts, Indications, and Practical GuidelinesJournal of Immunology Research, 2012
- C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progressTrends in Molecular Medicine, 2009
- Melkersson-Rosenthal syndrome revisited as a misdiagnosed diseaseAmerican Journal of Otolaryngology, 2008
- Melkerrson–Rosenthal syndrome with cardiac involvementJournal of Clinical Neuroscience, 2004
- Melkersson-Rosenthal syndrome in childhood: a challenge in differential diagnosis and treatmentBritish Journal of Dermatology, 2000